Coffee, Phosphoinositide 3-Kinase Signaling Pathway, and Prostate Cancer: A Prospective Study in the Health Professionals Follow-Up Study

被引:0
|
作者
Song, Rui [1 ,2 ]
Stopsack, Konrad H. [3 ,4 ,5 ]
Ren, Junkun [5 ,6 ,7 ]
Mucci, Lorelei A. [5 ]
Clinton, Steven K. [8 ,9 ,10 ]
Loda, Massimo [11 ,12 ]
Wang, Molin [5 ,13 ,14 ]
Giovannucci, Edward L. [2 ,5 ]
Wilson, Kathryn M. [5 ,15 ]
Smith-Warner, Stephanie A. [2 ,5 ]
机构
[1] Anal Grp, Boston, MA USA
[2] Harvard TH Chan Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA USA
[4] Harvard Med Sch, Boston, MA USA
[5] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[6] Cambridge Hosp, Cambridge, MA 02139 USA
[7] Woods Hole Oceanog Inst, Falmouth, MA 02543 USA
[8] Ohio State Univ, Coll Med, Dept Internal Med, Div Med Oncol, Columbus, OH USA
[9] Ohio State Univ, Arthur G James Canc Hosp, Genitourinary Oncol, Columbus, OH USA
[10] Ohio State Univ, Ctr Comprehens Canc, Mol Carcinogenesis & Chemoprevent Program, Columbus, OH 43210 USA
[11] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA
[12] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[13] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA
[14] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Dept Med, Boston, MA USA
[15] Navitas Data Sci, Pottstown, PA USA
基金
美国国家卫生研究院;
关键词
Cohort studies; Coffee; Nutrition; Prostate cancer; Tumor markers; GROWTH; ATROPHY; PTEN; CONSUMPTION; PROGRESSION; EXPRESSION; RISK;
D O I
10.1016/j.jand.2024.07.001
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background Higher coffee intake has been associated with reduced risk of prostate cancer, particularly aggressive forms. The activation of the phosphoinositide 3-kinase (PI3K) signaling pathway plays an important role in prostate carcinogenesis. Objective To evaluate associations between prediagnostic coffee intake and a PI3K activation score, the expression/presence of PI3K regulators, and downstream effectors in tumor tissue from men with prostate cancer in the Health Professionals Follow-Up Study, a prospective cohort study conducted in the United States. Design A case-only study design was applied. Coffee intake was assessed using validated food frequency questionnaires completed in 1986 and every 4 years thereafter until prostate cancer diagnosis. Participants setting Study participants comprised 1242 men diagnosed with prostate cancer from 1986 to 2009 and with tumor markers assessed from tissue microarrays constructed from tumor specimens. Main outcome measures The outcomes include the PI3K activation score; expression of insulin receptor and insulin-like growth factor 1 receptor; angiogenesis markers; and presence of the tumor suppressor phosphatase and tensin homolog, chronic and acute inflammation, simple atrophy, and post-atrophic hyperplasia. Statistical analyses performed Multivariable linear or logistic regression was conducted to estimate associations between coffee intake and tumor marker expression/ presence. Results Among coffee drinkers (86.6% of the population), median (25th, 75th percentile) coffee intake was 2 c/day (1, 3 c/day). The associations between coffee consumption and the tumor markers of interest were generally weak with modest precision. When comparing men who drank >3 c/day coffee with nondrinkers, the absolute percent difference in the PI3K activation score and angiogenesis markers ranged from 0.6% to 3.6%. The odds ratios for phosphatase and tensin homolog loss, insulin-like growth factor 1 receptor and insulin receptor expression, and presence of chronic and acute inflammation, simple atrophy, and postatrophic hyperplasia also were not statistically significant, were imprecise, and ranged from 0.82 to 1.58. Conclusions Coffee intake was not observed to be associated with PI3K activation, related regulators, and several effectors in prostate tumor tissue. Studies exploring alternative pathways or earlier steps in carcinogenesis are needed to investigate the underlying mechanisms of the coffee and prostate cancer association.
引用
收藏
页码:90 / 98.e5
页数:14
相关论文
共 50 条
  • [41] Alcohol and prostate cancer in the NHANES I epidemiologic follow-up study
    Breslow, RA
    Wideroff, L
    Graubard, BI
    Erwin, D
    Reichman, ME
    Ziegler, RG
    Ballard-Barbash, R
    ANNALS OF EPIDEMIOLOGY, 1999, 9 (04) : 254 - 261
  • [42] Cancer incidence in the Agricultural Health Study after 20 years of follow-up
    Lerro, Catherine C.
    Koutros, Stella
    Andreotti, Gabriella
    Sandler, Dale P.
    Lynch, Charles F.
    Louis, Lydia M.
    Blair, Aaron
    Parks, Christine G.
    Shrestha, Srishti
    Lubin, Jay H.
    Albert, Paul S.
    Hofmann, Jonathan N.
    Freeman, Laura E. Beane
    CANCER CAUSES & CONTROL, 2019, 30 (04) : 311 - 322
  • [43] Social integration and long-term physical and psychosocial quality of life among prostate cancer survivors in the Health Professionals Follow-up Study
    Chen, Naiyu
    Mcgrath, Colleen B.
    Stopsack, Konrad H.
    Morgans, Alicia K.
    Nethery, Rachel C.
    Dickerman, Barbra A.
    Mucci, Lorelei A.
    JOURNAL OF CANCER SURVIVORSHIP, 2024,
  • [44] Neighborhood greenness and long-term physical and psychosocial quality of life among prostate cancer survivors in the Health Professionals Follow-up Study
    Chen, Naiyu
    Hu, Cindy R.
    Iyer, Hari S.
    James, Peter
    Dickerman, Barbra A.
    Mucci, Lorelei A.
    Nethery, Rachel C.
    ENVIRONMENTAL RESEARCH, 2024, 262
  • [45] Coffee and incidence of diabetes in Swedish women: a prospective 18-year follow-up study
    Rosengren, A
    Dotevall, A
    Wilhelmsen, L
    Thelle, D
    Johansson, S
    JOURNAL OF INTERNAL MEDICINE, 2004, 255 (01) : 89 - 95
  • [46] The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer
    Carlos A. Castaneda
    Hernán Cortes-Funes
    Henry L. Gomez
    Eva M. Ciruelos
    Cancer and Metastasis Reviews, 2010, 29 : 751 - 759
  • [47] The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer
    Castaneda, Carlos A.
    Cortes-Funes, Hernan
    Gomez, Henry L.
    Ciruelos, Eva M.
    CANCER AND METASTASIS REVIEWS, 2010, 29 (04) : 751 - 759
  • [48] THE BRISTOL PROSTATE-CANCER PILOT SCREENING STUDY - A 3-YEAR FOLLOW-UP
    BREWSTER, SF
    KEMPLE, T
    MACIVER, AG
    ASTLEY, JP
    GINGELL, JC
    BRITISH JOURNAL OF UROLOGY, 1994, 74 (05): : 556 - 558
  • [49] RAPIDIRON Trial follow-up study - the RAPIDIRON-KIDS Study: protocol of a prospective observational follow-up study
    Derman, Richard J.
    Bellad, Roopa B.
    Bellad, Mrutyunjaya B.
    Bradford-Rogers, Jesse
    Georgieff, Michael K.
    Aghai, Zubair H.
    Thind, Simal
    Auerbach, Michael
    Boelig, Rupsa
    Leiby, Benjamin E.
    Short, Vanessa
    Yogeshkumar, S.
    Charantimath, Umesh S.
    Somannavar, Manjunath S.
    Mallapur, Ashalata A.
    Pol, Ramesh
    Ramadurg, Umesh
    Sangavi, Radha
    Peerapur, Basavaraj V.
    Banu, Nasima
    Patil, Praveen S.
    Patil, Amaresh P.
    Roy, Subarna
    Vastrad, Phaniraj
    Wallace, Dennis
    Shah, Hemang
    Goudar, Shivaprasad S.
    TRIALS, 2023, 24 (01)
  • [50] Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression
    Chikh, Anissa
    Ferro, Riccardo
    Abbott, Jonathan J.
    Pineiro, Roberto
    Buus, Richard
    Iezzi, Manuela
    Ricci, Francesca
    Bergamaschi, Daniele
    Ostano, Paola
    Chiorino, Giovanna
    Lattanzio, Rossano
    Broggini, Massimo
    Piantelli, Mauro
    Maffucci, Tania
    Falasca, Marco
    ONCOTARGET, 2016, 7 (14) : 18325 - 18345